found that the nuclear transcription factor Mesenchyme Homeobox 2 (MEOX2) contributes to the cell proliferation and motility of gliomas, and that cathepsin S of the cathepsin family of cysteine proteases is a downstream target of MEOX2 (186, 187). This evidence concerns the gene MEOX2 and central nervous system cancer.